Stereotactic Body Radiation Therapy (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC): Outcomes by Fractionation, Tumor Stage and Location, and Patient Operability: Early-Stage Non-Small Cell Lung Cancer

Abstract

Listen

Translate article

SBRT is first-line therapy for medically inoperable stage I NSCLC. Limited data exist assessing SBRT outcomes by ability to undergo resection, tumor size and location, and fractionation. We hypothesized local control (LC) would be similar across fractionation regimens and in operable and inoperable patients (pts), overall survival (OS) would be higher for operable pts, and LC would be lower with increasing T stage.